prednisolone has been researched along with Amyotrophic Lateral Sclerosis in 8 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Riluzole has recently been proven as the first effective drug for the treatment of amyotrophic lateral sclerosis (ALS)." | 7.78 | Riluzole-induced lung injury in two patients with amyotrophic lateral sclerosis. ( Arima, M; Chibana, K; Fukuda, T; Fukushima, F; Fukushima, Y; Hirata, H; Kakuta, T; Koichi, H; Shiobara, T; Soda, S; Sugiyama, K; Tatewaki, M; Watanabe, M, 2012) |
| "We herein investigated the clinical features of three patients with anti-muscle-specific tyrosine kinase (MuSK) antibody-positive myasthenia gravis (MG), which was initially difficult to distinguish from amyotrophic lateral sclerosis (ALS)." | 3.81 | Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis. ( Fujita, Y; Furuta, N; Ikeda, M; Ikeda, Y; Ishizawa, K; Makioka, K; Motomura, M; Nagamine, S; Okamoto, K; Shibata, M; Tsukagoshi, S; Yoshimura, S, 2015) |
| "Riluzole has recently been proven as the first effective drug for the treatment of amyotrophic lateral sclerosis (ALS)." | 3.78 | Riluzole-induced lung injury in two patients with amyotrophic lateral sclerosis. ( Arima, M; Chibana, K; Fukuda, T; Fukushima, F; Fukushima, Y; Hirata, H; Kakuta, T; Koichi, H; Shiobara, T; Soda, S; Sugiyama, K; Tatewaki, M; Watanabe, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, R | 1 |
| Nishikawa, N | 1 |
| Tsujii, T | 1 |
| Iwaki, H | 1 |
| Yabe, H | 1 |
| Nagai, M | 1 |
| Nomoto, M | 1 |
| Furuta, N | 1 |
| Ishizawa, K | 1 |
| Shibata, M | 1 |
| Tsukagoshi, S | 1 |
| Nagamine, S | 1 |
| Makioka, K | 1 |
| Fujita, Y | 1 |
| Ikeda, M | 1 |
| Yoshimura, S | 1 |
| Motomura, M | 1 |
| Okamoto, K | 1 |
| Ikeda, Y | 1 |
| Kakuta, T | 1 |
| Hirata, H | 1 |
| Soda, S | 1 |
| Shiobara, T | 1 |
| Watanabe, M | 1 |
| Tatewaki, M | 1 |
| Fukushima, F | 1 |
| Chibana, K | 1 |
| Sugiyama, K | 1 |
| Arima, M | 1 |
| Koichi, H | 1 |
| Fukuda, T | 1 |
| Fukushima, Y | 1 |
| Ikeda, K | 1 |
| Iwasaki, Y | 1 |
| Kinoshita, M | 1 |
| Bentes, C | 1 |
| de Carvalho, M | 1 |
| Valente, I | 1 |
| Sales Luis, ML | 1 |
| da Silva, JP | 1 |
| Werdelin, L | 1 |
| Boysen, G | 1 |
| Jensen, TS | 1 |
| Mogensen, P | 1 |
| de Jong, JM | 1 |
| den Hartog Jager, WA | 1 |
| Vyth, A | 1 |
| Timmer, JG | 1 |
| Baumann, J | 1 |
8 other studies available for prednisolone and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Human T-lymphotropic virus type-I (HTLV-I)-associated myelopathy with bulbar palsy-type amyotrophic lateral sclerosis-like symptoms.
Topics: Amyotrophic Lateral Sclerosis; Anti-Inflammatory Agents; Biomarkers; Bulbar Palsy, Progressive; Fema | 2015 |
Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Autoantibodies; Biomarkers; Deglutition Disorders; Disease Prog | 2015 |
Riluzole-induced lung injury in two patients with amyotrophic lateral sclerosis.
Topics: Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Excitatory Amino Acid Antagonists; Female; H | 2012 |
Amyotrophic lateral sclerosis associated with isolated adrenocorticotrophic hormone deficiency.
Topics: Adrenocorticotropic Hormone; Aged; Amyotrophic Lateral Sclerosis; Biopsy; Endocrine Glands; Humans; | 1995 |
Amyotrophic lateral sclerosis syndrome associated with connective tissue disease; improvement after immunosuppressive therapy. A long-term follow-up case.
Topics: Amyotrophic Lateral Sclerosis; Anti-Inflammatory Agents; Azathioprine; Connective Tissue Diseases; F | 1999 |
Immunosuppressive treatment of patients with amyotrophic lateral sclerosis.
Topics: Administration, Oral; Adult; Aged; Amyotrophic Lateral Sclerosis; Azathioprine; Female; Humans; Infu | 1990 |
Attempted treatment of motor neuron disease with N-acetylcysteine and dithiothreitol.
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Dithiothreitol; Drug Evaluation; Drug Hypersensitivit | 1987 |
Results of treatment of certain diseases of the central nervous system with ACTH and corticosteroids.
Topics: Adrenocorticotropic Hormone; Adult; Amyotrophic Lateral Sclerosis; Brain Diseases; Dystonia Musculor | 1965 |